Ditchcarbon
  • Contact
  1. Organizations
  2. Ipca Laboratories
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 14 days ago

Ipca Laboratories Sustainability Profile

Company website

Ipca Laboratories Limited, headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry, specialising in the manufacture and export of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1949, the company has achieved significant milestones, including a robust presence in over 100 countries and a diverse product portfolio that encompasses a wide range of therapeutic areas such as cardiovascular, anti-infective, and pain management. With a commitment to quality and innovation, Ipca Laboratories stands out for its extensive range of generic formulations and APIs, which are produced in state-of-the-art facilities adhering to international standards. The company has garnered a strong market position, recognised for its consistent growth and contributions to healthcare, making it a trusted name in the global pharmaceutical landscape.

DitchCarbon Score

How does Ipca Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Ipca Laboratories's score of 37 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

56%

Let us know if this data was useful to you

Ipca Laboratories's reported carbon emissions

In 2025, Ipca Laboratories reported total carbon emissions of approximately 582,391,000 kg CO2e, comprising 169,992,000 kg CO2e from Scope 1, 124,512,000 kg CO2e from Scope 2, and 287,887,000 kg CO2e from Scope 3 emissions. This data reflects a comprehensive approach to emissions reporting, with disclosures across all three scopes. For the previous year, 2024, the company recorded emissions of about 614,543,000 kg CO2e, with Scope 1 emissions at 174,538,000 kg CO2e, Scope 2 at 137,345,000 kg CO2e, and Scope 3 at 306,660,000 kg CO2e. In 2023, emissions were approximately 304,994,000 kg CO2e, with Scope 1 at 124,880,000 kg CO2e and Scope 2 at 179,114,000 kg CO2e. Ipca Laboratories has set ambitious targets to reduce its carbon footprint, aiming for a 20% reduction in Scope 1 and Scope 2 emissions by 2030, with the baseline year being 2022. This commitment aligns with their broader climate strategy, which includes a near-term target for Scope 1 emissions reduction. The company is also committed to achieving net-zero emissions, as indicated by their status with the Science Based Targets initiative (SBTi). This commitment underscores their dedication to sustainable practices within the pharmaceutical sector, reflecting a proactive stance on climate change and environmental responsibility.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192022202320242025
Scope 1
51,938,620
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
598,518,280
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
6,451,465,560
-
-
000,000,000
000,000,000

How Carbon Intensive is Ipca Laboratories's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ipca Laboratories's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Ipca Laboratories's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ipca Laboratories is in IN, which has a very high grid carbon intensity relative to other regions.

Ipca Laboratories's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Ipca Laboratories has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Ipca Laboratories's Emissions with Industry Peers

Cipla

IN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Torrent Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Mankind Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Abbott India Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Frequently Asked Questions

Common questions about Ipca Laboratories's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251112.6
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy